Incidental Mutation 'R7047:Tnfrsf19'
ID 547386
Institutional Source Beutler Lab
Gene Symbol Tnfrsf19
Ensembl Gene ENSMUSG00000060548
Gene Name tumor necrosis factor receptor superfamily, member 19
Synonyms TAJ, TRADE, TAJ-ALPHA, Troy
MMRRC Submission 045145-MU
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # R7047 (G1)
Quality Score 225.009
Status Validated
Chromosome 14
Chromosomal Location 61201324-61283939 bp(-) (GRCm39)
Type of Mutation nonsense
DNA Base Change (assembly) A to T at 61242667 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Cysteine to Stop codon at position 72 (C72*)
Ref Sequence ENSEMBL: ENSMUSP00000152920 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000111234] [ENSMUST00000111236] [ENSMUST00000224371] [ENSMUST00000225730]
AlphaFold Q9JLL3
Predicted Effect probably null
Transcript: ENSMUST00000111234
AA Change: C72*
SMART Domains Protein: ENSMUSP00000106865
Gene: ENSMUSG00000060548
AA Change: C72*

DomainStartEndE-ValueType
signal peptide 1 29 N/A INTRINSIC
TNFR 34 72 1.75e0 SMART
TNFR 75 114 3.32e-1 SMART
transmembrane domain 169 191 N/A INTRINSIC
Predicted Effect probably null
Transcript: ENSMUST00000111236
AA Change: C72*
SMART Domains Protein: ENSMUSP00000106867
Gene: ENSMUSG00000060548
AA Change: C72*

DomainStartEndE-ValueType
signal peptide 1 29 N/A INTRINSIC
TNFR 34 72 1.75e0 SMART
TNFR 75 114 3.32e-1 SMART
transmembrane domain 169 191 N/A INTRINSIC
Predicted Effect probably null
Transcript: ENSMUST00000224371
AA Change: C72*
Predicted Effect probably null
Transcript: ENSMUST00000225730
AA Change: C72*
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 100.0%
  • 10x: 99.7%
  • 20x: 99.1%
Validation Efficiency 98% (53/54)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is highly expressed during embryonic development. It has been shown to interact with TRAF family members, and to activate JNK signaling pathway when overexpressed in cells. This receptor is capable of inducing apoptosis by a caspase-independent mechanism, and it is thought to play an essential role in embryonic development. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygous mutant mice exhibit no obvious physical abnormalities or alterations in behavior, locomotion, or fecundity, however neurons are more resistant to the suppressive action of myelin inhibitors. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 53 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
3425401B19Rik A T 14: 32,382,131 (GRCm39) I1278N possibly damaging Het
Adcy5 T A 16: 35,087,585 (GRCm39) L482Q probably damaging Het
Adora2a A G 10: 75,162,145 (GRCm39) I95V probably damaging Het
Anapc1 A C 2: 128,457,350 (GRCm39) C1887G probably damaging Het
Arfgef2 T A 2: 166,693,865 (GRCm39) probably null Het
Capn11 G T 17: 45,949,622 (GRCm39) S448* probably null Het
Capn7 C T 14: 31,058,642 (GRCm39) probably benign Het
Cep55 T A 19: 38,048,539 (GRCm39) V65D possibly damaging Het
Col5a1 A G 2: 27,818,096 (GRCm39) K107R unknown Het
Dbh T A 2: 27,055,622 (GRCm39) I32N possibly damaging Het
Disp1 C A 1: 182,869,030 (GRCm39) R1130L probably damaging Het
Dzip3 A T 16: 48,802,489 (GRCm39) N13K probably benign Het
Emilin1 A G 5: 31,074,422 (GRCm39) N221S probably benign Het
Ext2 A G 2: 93,570,002 (GRCm39) F470L probably damaging Het
Filip1 T A 9: 79,760,916 (GRCm39) Q206L probably damaging Het
Garin1b T A 6: 29,323,809 (GRCm39) L178H probably damaging Het
Gpr63 G T 4: 25,007,320 (GRCm39) A15S probably benign Het
Grhl3 T C 4: 135,276,551 (GRCm39) probably null Het
Hspa5 C T 2: 34,663,204 (GRCm39) P127L probably damaging Het
Ift172 G T 5: 31,433,238 (GRCm39) Y193* probably null Het
Ints1 A C 5: 139,744,226 (GRCm39) L1512* probably null Het
Kat2b A G 17: 53,970,597 (GRCm39) Q661R probably benign Het
Kat6a A G 8: 23,428,554 (GRCm39) N1303S possibly damaging Het
L3mbtl4 G T 17: 68,768,561 (GRCm39) R223L probably benign Het
Maml2 T C 9: 13,532,177 (GRCm39) probably benign Het
Mixl1 A G 1: 180,524,183 (GRCm39) probably null Het
Mocs1 T C 17: 49,759,887 (GRCm39) probably null Het
Ms4a15 T G 19: 10,962,236 (GRCm39) N36T probably damaging Het
Msr1 G A 8: 40,095,657 (GRCm39) T2I possibly damaging Het
Nlgn1 A C 3: 25,490,199 (GRCm39) Y509* probably null Het
Nsmce1 C A 7: 125,090,606 (GRCm39) G4C probably benign Het
Or4c113 A T 2: 88,885,490 (GRCm39) F93L probably damaging Het
Or51v15-ps1 A G 7: 103,278,918 (GRCm39) V83A probably damaging Het
Pan3 G A 5: 147,483,175 (GRCm39) G452D probably damaging Het
Pcyox1 G T 6: 86,365,891 (GRCm39) P441H probably damaging Het
Phf12 T C 11: 77,904,099 (GRCm39) V273A probably damaging Het
Plcd4 A G 1: 74,591,148 (GRCm39) E181G possibly damaging Het
Ptgfr A T 3: 151,541,178 (GRCm39) I110N possibly damaging Het
Rab40c A C 17: 26,138,458 (GRCm39) V8G probably damaging Het
Rasal3 T A 17: 32,615,458 (GRCm39) Y460F probably damaging Het
Rhbdf2 A G 11: 116,494,477 (GRCm39) probably null Het
Ryr2 T A 13: 11,839,286 (GRCm39) N496Y possibly damaging Het
Sacs A T 14: 61,450,451 (GRCm39) I4166F probably damaging Het
Sh2d3c T C 2: 32,611,172 (GRCm39) M1T probably null Het
Smarca2 C T 19: 26,646,555 (GRCm39) S651L possibly damaging Het
Sned1 A T 1: 93,213,540 (GRCm39) R1204S possibly damaging Het
Spata31d1b T C 13: 59,860,249 (GRCm39) Y41H probably damaging Het
Stab2 C T 10: 86,694,016 (GRCm39) C2075Y probably damaging Het
Tcte1 A T 17: 45,844,294 (GRCm39) Q90L possibly damaging Het
Tll2 C T 19: 41,074,679 (GRCm39) G945S probably damaging Het
Tmbim7 A T 5: 3,720,112 (GRCm39) T116S probably benign Het
Usp17le T A 7: 104,417,640 (GRCm39) T501S probably benign Het
Wnt5b T A 6: 119,425,217 (GRCm39) probably benign Het
Other mutations in Tnfrsf19
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00943:Tnfrsf19 APN 14 61,261,631 (GRCm39) missense possibly damaging 0.53
IGL01564:Tnfrsf19 APN 14 61,212,058 (GRCm39) missense possibly damaging 0.85
IGL01878:Tnfrsf19 APN 14 61,234,093 (GRCm39) missense probably damaging 0.98
IGL02220:Tnfrsf19 APN 14 61,210,941 (GRCm39) unclassified probably benign
IGL02378:Tnfrsf19 APN 14 61,208,451 (GRCm39) missense probably benign 0.00
IGL02546:Tnfrsf19 APN 14 61,210,987 (GRCm39) missense possibly damaging 0.86
IGL02583:Tnfrsf19 APN 14 61,261,659 (GRCm39) missense probably damaging 0.98
IGL03037:Tnfrsf19 APN 14 61,261,721 (GRCm39) missense possibly damaging 0.83
IGL03221:Tnfrsf19 APN 14 61,262,227 (GRCm39) missense probably benign 0.06
R0241:Tnfrsf19 UTSW 14 61,211,041 (GRCm39) missense possibly damaging 0.93
R0373:Tnfrsf19 UTSW 14 61,209,485 (GRCm39) missense possibly damaging 0.47
R1521:Tnfrsf19 UTSW 14 61,242,555 (GRCm39) missense probably damaging 0.99
R3038:Tnfrsf19 UTSW 14 61,209,512 (GRCm39) missense probably benign
R4346:Tnfrsf19 UTSW 14 61,209,429 (GRCm39) critical splice donor site probably null
R4997:Tnfrsf19 UTSW 14 61,208,658 (GRCm39) missense probably benign
R5756:Tnfrsf19 UTSW 14 61,262,224 (GRCm39) missense probably benign
R5869:Tnfrsf19 UTSW 14 61,208,627 (GRCm39) missense possibly damaging 0.70
R6110:Tnfrsf19 UTSW 14 61,208,588 (GRCm39) missense probably benign 0.08
R7266:Tnfrsf19 UTSW 14 61,212,147 (GRCm39) missense possibly damaging 0.91
R7491:Tnfrsf19 UTSW 14 61,242,654 (GRCm39) missense possibly damaging 0.75
R7729:Tnfrsf19 UTSW 14 61,212,183 (GRCm39) missense possibly damaging 0.70
R7936:Tnfrsf19 UTSW 14 61,208,382 (GRCm39) missense probably benign 0.22
R8358:Tnfrsf19 UTSW 14 61,208,634 (GRCm39) missense probably benign 0.25
R8535:Tnfrsf19 UTSW 14 61,208,417 (GRCm39) missense probably benign 0.25
R8693:Tnfrsf19 UTSW 14 61,208,451 (GRCm39) missense probably benign
R9028:Tnfrsf19 UTSW 14 61,242,650 (GRCm39) missense probably benign 0.26
R9468:Tnfrsf19 UTSW 14 61,261,623 (GRCm39) missense possibly damaging 0.93
Predicted Primers PCR Primer
(F):5'- AAAGAGAAGTCATGGCCCTAC -3'
(R):5'- AAAGTGGATTGCTAAGGACCC -3'

Sequencing Primer
(F):5'- GAGAAGTCATGGCCCTACTCACC -3'
(R):5'- ATTGCTAAGGACCCTTGCG -3'
Posted On 2019-05-13